Marshall Wace’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Marshall Wace’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,946	Closed	-$331K	–	4475
2021 Q3	$331K	Buy	+27,946	New	+$407K	﹤0.01%	2599
2020 Q4	–	Sell	-13,177	Closed	-$278K	–	2293
2020 Q3	$278K	Sell	13,177 -9,981	-43%	-$233K	﹤0.01%	1381
2020 Q2	$669K	Buy	+23,158	New	+$698K	﹤0.01%	1111

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Marshall Wace's OYST Position: Q4 2021 in Review

Marshall Wace sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2021, closing a stake of 27,946 shares — an estimated $331K sold.

Marshall Wace first reported a position in OYST in Q2 2020 and held it in 3 quarters. The position peaked at $669K in Q2 2020. 80 funds tracked by Wall St. Rank hold OYST as of Q4 2021.

Marshall Wace reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Marshall Wace sold 27,946 Oyster Point Pharma, Inc. Common Stock shares in Q4 2021, an estimated $331K.
Marshall Wace first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
Marshall Wace's Oyster Point Pharma, Inc. Common Stock position peaked at $669K in Q2 2020.
80 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.